These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 14768953

  • 1. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI, Amengual O, Atsumi T, Khamashta MA, Tinahones FJ, Hughes GR.
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Aug; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 9. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I.
    Lupus; 2006 Aug; 15(2):80-6. PubMed ID: 16539278
    [Abstract] [Full Text] [Related]

  • 10. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 11. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughes GR.
    Lupus; 2003 Nov; 12(7):550-4. PubMed ID: 12892397
    [Abstract] [Full Text] [Related]

  • 12. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
    Matsuura E, Kobayashia K, Koikeb T, Shoenfeld Y, Khamashta MA, Hughes GR.
    Immunobiology; 2003 Nov; 207(1):17-22. PubMed ID: 12638898
    [Abstract] [Full Text] [Related]

  • 13. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K, Lopez LR, Matsuura E.
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [Abstract] [Full Text] [Related]

  • 14. Autoantibody-mediated atherosclerosis.
    Matsuura E, Kobayashi K, Koike T, Shoenfeld Y.
    Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Dec; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 16. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.
    Kobayashi K, Matsuura E, Liu Q, Furukawa J, Kaihara K, Inagaki J, Atsumi T, Sakairi N, Yasuda T, Voelker DR, Koike T.
    J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976
    [Abstract] [Full Text] [Related]

  • 17. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
    Kobayashi K, Kishi M, Atsumi T, Bertolaccini ML, Makino H, Sakairi N, Yamamoto I, Yasuda T, Khamashta MA, Hughes GR, Koike T, Voelker DR, Matsuura E.
    J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
    [Abstract] [Full Text] [Related]

  • 18. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P.
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [Abstract] [Full Text] [Related]

  • 19. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E, Lopez LR.
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [Abstract] [Full Text] [Related]

  • 20. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
    Berger JS, Rockman CB, Guyer KE, Lopez LR.
    J Immunol Res; 2014 Jun; 2014():234316. PubMed ID: 25405208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.